Keystone EC - Search Results

1

Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.

McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, Boire G, Haraoui B, Ferland DS, Keystone EC, Pope JE; CATCH Investigators. McKeown E, et al. Among authors: keystone ec. Rheumatology (Oxford). 2012 Sep;51(9):1662-9. doi: 10.1093/rheumatology/kes079. Epub 2012 Apr 25. Rheumatology (Oxford). 2012. PMID: 22539481

2

Systemic vasculitis following influenza vaccination--report of 3 cases and literature review.

Mader R, Narendran A, Lewtas J, Bykerk V, Goodman RC, Dickson JR, Keystone EC. Mader R, et al. Among authors: keystone ec. J Rheumatol. 1993 Aug;20(8):1429-31. J Rheumatol. 1993. PMID: 8230034 Review.

3

Thalidomide in the treatment of refractory rheumatoid arthritis.

Keesal N, Wasserman MJ, Bookman A, Lapp V, Weber DA, Keystone EC. Keesal N, et al. Among authors: keystone ec. J Rheumatol. 1999 Nov;26(11):2344-7. J Rheumatol. 1999. PMID: 10555888 Clinical Trial.

4

Biologic agents in the treatment of rheumatoid arthritis.

Haraoui B, Strand V, Keystone E. Haraoui B, et al. Curr Pharm Biotechnol. 2000 Nov;1(3):217-33. doi: 10.2174/1389201003378915. Curr Pharm Biotechnol. 2000. PMID: 11469381 Review.

5

Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in canada.

Russell A, Haraoui B, Keystone E, Klinkhoff A. Russell A, et al. Clin Ther. 2001 Nov;23(11):1824-38; discussion 1791. doi: 10.1016/s0149-2918(00)80079-x. Clin Ther. 2001. PMID: 11768835 Review.

6

Role of adalimumab in the treatment of early rheumatoid arthritis.

Keystone EC, Haraoui B, Bykerk VP. Keystone EC, et al. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S198-9. Clin Exp Rheumatol. 2003. PMID: 14969077 Clinical Trial.

7

Role of infliximab in the treatment of early rheumatoid arthritis.

Keystone EC, Haraoui B, Bykerk VP. Keystone EC, et al. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S200-2. Clin Exp Rheumatol. 2003. PMID: 14969078 Review.

8

Safety issues related to emerging therapies for rheumatoid arthritis.

Keystone EC. Keystone EC. Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S148-50. Clin Exp Rheumatol. 2004. PMID: 15552529 Review.

9

What are the goals and principles of management in the early treatment of rheumatoid arthritis?

Bykerk VP, Keystone EC. Bykerk VP, et al. Among authors: keystone ec. Best Pract Res Clin Rheumatol. 2005 Feb;19(1):147-61. doi: 10.1016/j.berh.2004.08.011. Best Pract Res Clin Rheumatol. 2005. PMID: 15588976 Review.

10

Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity.

Galligan CL, Baig E, Bykerk V, Keystone EC, Fish EN. Galligan CL, et al. Among authors: keystone ec. Genes Immun. 2007 Sep;8(6):480-91. doi: 10.1038/sj.gene.6364400. Epub 2007 Jun 14. Genes Immun. 2007. PMID: 17568789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters